Forecast & Rating5 analysts currently cover Lakefront Biotherapeutics, with about 0.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $23.61, about 14.2% downside from the current price of $27.52. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most institutions are cautious on Lakefront Biotherapeutics's outlook. Data as of Aug 12, 2026; for reference only and not investment advice.
Aug 11, 2026Price forecast
$23.61-14.21%
Forecast & RatingHold
5analysts
- Strong buy0.00%
- Buy0.00%
- Hold80.00%
- Sell20.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met8.7%
Stock price$27.52
Avg. target$23.6
High target$26
Low target$19
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.